- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 159-173 of
300 results
2012 Exhibit: Renier J Brentjens et al, Safety and persistence of adoptively transfe...
Document
IPR2022-00855, No. 2012-58 Exhibit - Renier J Brentjens et al, Safety and persistence of adoptively transferred autologous CD19 targeted T cells in patients with relapsed or chemotherapy refra...
|
|
Cite Document
2021 Exhibit: Carl June Named One of Time���s 100 Most Influential People in the W...
Document
IPR2022-00855, No. 2021-67 Exhibit - Carl June Named One of Time���s 100 Most Influential People in the World, PENN MEDICINE Apr 26, 2018, httpspathologymedupennedunewscarl june nam...
|
|
Cite Document
2040 Exhibit: ASH honors Bruce R Blazar, MD, and Carl H June, MD, with 2012 Ern...
Document
IPR2022-00855, No. 2040-86 Exhibit - ASH honors Bruce R Blazar, MD, and Carl H June, MD, with 2012 Ernest Beutler Lecture and Prize, SCIENCEX Aug 27, 2012, httpssciencexcomwire news1...
|
|
Cite Document
2027 Exhibit: Supplemental Information Disclosure Statement Initialed by Examine...
Document
IPR2022-00855, No. 2027-73 Exhibit - Supplemental Information Disclosure Statement Initialed by Examiner Apr 18, 2016, US Patent Application No 14,997,136 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2034 Exhibit: David L Porter et al, A phase 1 trial of donor lymphocyte infusions exp...
Document
IPR2022-00855, No. 2034-80 Exhibit - David L Porter et al, A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3CD28 costimulation, 107 BLOOD 1325 2006 (P.T...
|
|
Cite Document
2040 Exhibit: ASH honors Bruce R Blazar, MD, and Carl H June, MD, with 2012 Ern...
Document
IPR2022-00855, No. 2040-86 Exhibit - ASH honors Bruce R Blazar, MD, and Carl H June, MD, with 2012 Ernest Beutler Lecture and Prize, SCIENCEX Aug 27, 2012, httpssciencexcomwire news1...
|
|
Cite Document
2012 Exhibit: Renier J Brentjens et al, Safety and persistence of adoptively transfe...
Document
IPR2022-00855, No. 2012-58 Exhibit - Renier J Brentjens et al, Safety and persistence of adoptively transferred autologous CD19 targeted T cells in patients with relapsed or chemotherapy refra...
|
|
Cite Document
2039 Exhibit: Cor HJ Lamers et al, Treatment of Metastatic Renal Cell Carcinoma W...
Document
IPR2022-00855, No. 2039-85 Exhibit - Cor HJ Lamers et al, Treatment of Metastatic Renal Cell Carcinoma With Autologous T Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX...
|
|
Cite Document
2022 Exhibit: Holly Auer, Penn Medicine Immunotherapy Pioneer Carl June, MD, A...
Document
IPR2022-00855, No. 2022-68 Exhibit - Holly Auer, Penn Medicine Immunotherapy Pioneer Carl June, MD, Awarded 2015 Paul Ehrlich and Ludwig Darmstaedter Prize, PENN TODAY Mar 11, 201...
|
|
Cite Document
2039 Exhibit: Cor HJ Lamers et al, Treatment of Metastatic Renal Cell Carcinoma W...
Document
IPR2022-00855, No. 2039-85 Exhibit - Cor HJ Lamers et al, Treatment of Metastatic Renal Cell Carcinoma With Autologous T Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX...
|
|
Cite Document
2013 Exhibit: Renier Brentjens et al, Treatment of chronic lymphocytic leukemia wit...
Document
IPR2022-00855, No. 2013-59 Exhibit - Renier Brentjens et al, Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells case report of an unforeseen adverse event ...
|
|
Cite Document
1052 Exhibit: Arnold Declaration
Document
IPR2022-00855, No. 1052 Exhibit - Arnold Declaration (P.T.A.B. Apr. 12, 2022)
|
|
Cite Document
2073 Exhibit: EX 2073
Document
IPR2022-00855, No. 2073 Exhibit - EX 2073 (P.T.A.B. Feb. 13, 2023)
|
|
Cite Document
2025 Exhibit: Agilent Presents Thought Leader Award to Drs Carl H June and Micha...
Document
IPR2022-00855, No. 2025 Exhibit - Agilent Presents Thought Leader Award to Drs Carl H June and Michael Milone, AGILENT TECHS INC Nov 17, 2020, httpswwwagilentcomaboutnewsroompres...
|
|
Cite Document
2037 Exhibit: Bipulendu Jena et al, Redirecting T cell specificity by introducing a tum...
Document
IPR2022-00855, No. 2037 Exhibit - Bipulendu Jena et al, Redirecting T cell specificity by introducing a tumor specific chimeric antigen receptor, 116 BLOOD 1035 2010 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
